Large-scale Studies Needed to Guide Newborn Screening for Rare Diseases
August 2nd 2022Despite the known potential benefits of newborn screening, the exact long-term clinical benefits and cost-effectiveness in large cohorts remain uncertain due to a lack of large-scale longitudinal research.
Read More
Gulati on Unequal CV Treatment for Women: “There Is a Bias in Our Care”
August 1st 2022Martha Gulati, MD, MS, kicked off the symposium “Saving the Hearts of Women Through Prevention” ahead of the 2022 Congress of the American Society for Preventive Cardiology, which took place Friday through Sunday in Louisville, Kentucky.
Read More
Model Suggests Giving Kidneys to Patients on Dialysis a Better Use of Resources
August 1st 2022A recent modeling study found that allocating kidneys to patients receiving dialysis was a better use of the organs from a societal perspective compared with giving kidneys to those on a preemptive waiting list.
Read More
Heavy/Light Chain Assay Useful Marker in Cold Agglutinin Disease, Study Suggests
August 1st 2022Current standard modalities for detecting and quantifying monoclonal immunoglobin in patients with cold agglutinin disease lack adequate sensitivity. Heavy chain/light chain assay may be more effective.
Read More
The first case of polio in the United States in nearly a decade demonstrated a potential link to vaccine-derived viruses in Jerusalem and London; the world’s first HIV-positive heart transplant has been performed in the Bronx; North Carolina is on the path to Medicaid expansion.
Read More
Social Determinants, Including Racism, Are Major Drivers of Health Inequity, Watson Says
July 31st 2022Social determinants of health are major drivers of the inequities seen in health outcomes, and racism is clearly a social determinant tied to life expectancy, said Karol Watson, MD, PhD, in talk Sunday at the 2022 Congress of the American Society for Preventive Cardiology, held in Louisville, Kentucky.
Read More
Gluckman Calls for Better Data, Payer Policies to Drive Value-Based CV Care
July 30th 2022Ty J. Gluckman, MD, FACC, FAHA, who is medical director of the Center for Cardiovascular Analytics, Research, and Data Science at Providence St. Joseph Health in Portland, Oregon, addressed the 2022 Congress of the American Society for Preventive Cardiology meeting in Louisville, Kentucky.
Read More
GVHD May Mimic Eosinophilic GI Disorders Following Bone Marrow Transplant
July 30th 2022After years of dependence on systemic corticosteroids, ruxolitinib treatment was effective for an adolescent patient with graft-versus-host disease (GVHD) who was initially thought to have eosinophilic gastroenteritis.
Read More
Noninvasive Ventilation at Home Lowers Mortality and Health Care Costs in Hypercapnic COPD-CRF
July 30th 2022Starting noninvasive ventilation at home (NIVH) early after diagnosis was correlated with lower risk of death and reduced Medicare spending for patients with hypercapnic chronic obstructive pulmonary disease with chronic respiratory failure (COPD-CRF), according to a recent study.
Read More
Duke’s Douglas Highlights Need for Respect in Promoting Diversity, Health Equity
July 30th 2022Duke University’s Pamela S. Douglas, MD, spoke to cardiology professionals who gathered for the start of the 2022 Congress of the American Society for Preventive Cardiology (ASPC), in Louisville, Kentucky.
Read More
Study Identifies Risk Factors for Thrombosis in Patients With AIHA
July 29th 2022This retrospective study and prospective follow-up provide insight into predictors of thrombotic episodes in patients with autoimmune hemolytic anemia (AIHA) and indicators that anticoagulant prophylaxis may be beneficial to certain patients.
Read More
Dr Anchalee Avihingsanon: ALLIANCE Trial Findings Are Meaningful for HIV/HBV Coinfection
July 29th 2022The ALLIANCE trial is the first randomized blinded trial to investigate tenofovir alafenamide vs tenofovir disoproxil fumarate in treatment-naive individuals who have comorbid HIV/hepatitis B virus (HBV) infection.
Watch
Overuse of Systemic Corticosteroids, Substantial Cost Burden for AD Seen in Germany
July 29th 2022Systemic corticosteroids were more commonly prescribed vs other systemic drug options in Germany for patients with atopic dermatitis (AD) despite their unfavorable risk-benefit profile, with a substantial economic burden cited among these populations.
Read More
Time-Restricted Eating Improves Glucose Control for Patients With Type 2 Diabetes
July 29th 2022Following a time-restricted eating schedule, limited to a 10-hour window, provides beneficial metabolic effects and the potential for weight loss in patients with type 2 diabetes, according to a new study.
Read More